114 related articles for article (PubMed ID: 23274150)
1. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor.
Swiecki M; Omattage NS; Brett TJ
Mol Immunol; 2013 Jun; 54(2):132-9. PubMed ID: 23274150
[TBL] [Abstract][Full Text] [Related]
2. Tetherin and its viral antagonists.
Kuhl BD; Cheng V; Wainberg MA; Liang C
J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
[TBL] [Abstract][Full Text] [Related]
3. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps.
Berry KN; Kober DL; Su A; Brett TJ
Bioessays; 2018 Oct; 40(10):e1800086. PubMed ID: 30113067
[TBL] [Abstract][Full Text] [Related]
4. Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein.
Zadeh VR; Urata S; Sakaguchi M; Yasuda J
J Gen Virol; 2020 Jun; 101(6):573-586. PubMed ID: 32375950
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.
Kong WS; Irie T; Yoshida A; Kawabata R; Kadoi T; Sakaguchi T
Hiroshima J Med Sci; 2012 Sep; 61(3):59-67. PubMed ID: 23077864
[TBL] [Abstract][Full Text] [Related]
6. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
Heusinger E; Kluge SF; Kirchhoff F; Sauter D
J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
[TBL] [Abstract][Full Text] [Related]
8. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.
Dufrasne FE; Lombard C; Goubau P; Ruelle J
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754450
[TBL] [Abstract][Full Text] [Related]
9. Counteraction of the multifunctional restriction factor tetherin.
Sauter D
Front Microbiol; 2014; 5():163. PubMed ID: 24782851
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of HBV Release by BST-2].
Han Z; Yu X; Zhang W
Bing Du Xue Bao; 2016 Mar; 32(2):215-21. PubMed ID: 27396167
[TBL] [Abstract][Full Text] [Related]
11. Bending of the BST-2 coiled-coil during viral budding.
Ozcan KA; Berndsen CE
Proteins; 2017 Nov; 85(11):2081-2087. PubMed ID: 28779494
[TBL] [Abstract][Full Text] [Related]
12. High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2.
Zhang Q; Liu Z; Mi Z; Li X; Jia P; Zhou J; Yin X; You X; Yu L; Guo F; Ma J; Liang C; Cen S
Antiviral Res; 2011 Sep; 91(3):321-9. PubMed ID: 21777622
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.
Dafa-Berger A; Kuzmina A; Fassler M; Yitzhak-Asraf H; Shemer-Avni Y; Taube R
Virology; 2012 Jul; 428(2):98-111. PubMed ID: 22520941
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism.
Arias JF; Iwabu Y; Tokunaga K
Front Microbiol; 2011; 2():250. PubMed ID: 22180752
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity and Adaptive Evolution of Avian Tetherins.
Krchlíková V; Fábryová H; Hron T; Young JM; Koslová A; Hejnar J; Strebel K; Elleder D
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238588
[TBL] [Abstract][Full Text] [Related]
16. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?
Andrew A; Strebel K
J Interferon Cytokine Res; 2011 Jan; 31(1):137-44. PubMed ID: 21166593
[TBL] [Abstract][Full Text] [Related]
17. Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release.
Swiecki M; Scheaffer SM; Allaire M; Fremont DH; Colonna M; Brett TJ
J Biol Chem; 2011 Jan; 286(4):2987-97. PubMed ID: 21084286
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
Fritz JV; Tibroni N; Keppler OT; Fackler OT
Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
[TBL] [Abstract][Full Text] [Related]
20. The Disulfide Bonds within BST-2 Enhance Tensile Strength during Viral Tethering.
Du Pont KE; McKenzie AM; Kokhan O; Sumner I; Berndsen CE
Biochemistry; 2016 Feb; 55(6):940-7. PubMed ID: 26789136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
